1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ivabradine
Trade Name:
Lancora
Manufacturer/Distributor:
Servier Canada Inc.
Classification:
Cardiac medication
ATC Class:
C01EB - other cardiac preparations
Status:
active
Notice of Compliance (yyyy/mm/dd):
2016/12/23
Date Marketed in Canada (yyyy/mm/dd):
2017/04
Presentation:
Tablet: 5 mg. DIN: 02459973
Tablet: 7.5 mg. DIN: 02459981
Comments:
Ivabradine is indicated for the treatment of stable chronic heart failure with reduced left ventricular ejection fraction (≤ 35%) in adult patients with NYHA Classes II or III who are in sinus rhythm with a resting heart rate ≥ 77 beats per minute, to reduce the incidence of cardiovascular mortality and hospitalisations for worsening heart failure. It should be administered in combination with standard chronic heart failure therapies.
Back to:
Drug Product Listings 
